Suchergebnisse - "Carretero-Hernández, Gregorio"

PubPharm (19)

1

Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks : A retrospective, observational, multicentre study by the Spanish Psoriasis Group

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Berenguer-Ruiz, S. | Aparicio-Domínguez, M. | Herranz-Pinto, P. | +23

2

Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real‐world settings at 24 weeks : A retrospective, observational, multicentre study by the Spanish Psoriasis Group

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2023

von Berenguer‐Ruiz, S. | Aparicio‐Domínguez, M. | Herranz‐Pinto, P. | +22

3

Ocrelizumab‐induced psoriasiform dermatitis : Case reports and review of the literature

enthalten in: JEADV Clinical Practice | 2023

von Naranjo Guerrero, N. | González Quesada, A. | García Minarro, A. | +3

4

Maculopapular eruptions associated to COVID-19 : A subanalysis of the COVID-Piel study

enthalten in: Dermatologic therapy | 2020

von Català, A. | Galván-Casas, C. | Carretero-Hernández, G. | +21

5

Maculopapular eruptions associated to COVID‐19 : A subanalysis of the COVID‐Piel study

enthalten in: Dermatologic Therapy | 2020

von Català, A. | Galván‐Casas, C. | Carretero‐Hernández, G. | +21

6

Effectiveness and safety of Methotrexate in psoriasis : an eight-year experience with 218 patients

enthalten in: The Journal of dermatological treatment | 2017

von Cabello Zurita, C. | Grau Pérez, M. | Hernández Fernández, C. | +4

7

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

enthalten in: The British journal of dermatology | 2017

von García-Doval, I. | Hernández, M. | Vanaclocha, F. | +66

CommentIn: Br J Dermatol. 2017 Mar;176(3):567-568. - PMID 28300311

8

Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients

enthalten in: The journal of dermatological treatment | 2017

von Cabello Zurita, C. | Grau Pérez, M. | Hernández Fernández, C. | +4

9

Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

enthalten in: The British journal of dermatology | 2017

von García‐Doval, I. | Hernández, M. | Vanaclocha, F. | +65

10

MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population

enthalten in: Archives of dermatological research | 2014

von Córdoba-Lanús, E. | Hernández-Jiménez, J. | Medina-Coello, C. | +8